Abstract:
어플리케이션을업데이트하는방법및 장치가제공된다. 전자장치는설치된어플리케이션에대한자동업데이트를활성화할수 있다. 전자장치는어플리케이션을업데이트주기에따라구분된적어도하나의그룹중 하나의그룹으로지정할수 있다. 전자장치는지정된그룹에대응하는업데이트주기가되는시점이후에어플리케이션이업데이트되도록제어할수 있다.
Abstract:
A wearable video device according to an embodiment of the present invention includes first and second hangers adapted to be worn by a user; a first camera module installed on the first hanger and having a first axial shaft rotated outward by a first set angle from a center axis of the video device to produce a first image; a second camera module installed on the second hanger and having a second axial shaft rotated outward by a second set angle from the center axis of the video device to produce a second image; and a main circuit adapted to control the first camera module and the second camera module and to process at least a portion of the first image and the second image, wherein a first view of the first camera module and a second view of the second camera module are partially laid upon top of each other.
Abstract:
The present invention relates to a liposome comprising an elastin-like polypeptide (ELP) conjugated to a moiety containing a hydrophobic group, a chemosensitizer, and an anticancer agent, wherein the ELP conjugated to moiety containing the hydrophobic group is filled in a lipid bilayer. The present invention provides a pharmaceutical composition including the liposome and a method for delivering the chemosensitizer and the anticancer agent to a target site of a subject by using the liposome. [Reference numerals] (AA) Cell viability(%); (BB) Free doxorubicin; (CC) Glass doxorubicin
Abstract:
PURPOSE: A liposome containing an elastine-like polypeptide(ELP) and a use thereof are provided to reduce the amount of drug release, and to maintain stable state. CONSTITUTION: A liposome contains: a lipid bilayer; an elastine-like polypeptide(ELP) in which hydrophobic group-containing moiety is conjugated; and a lipid bilayer stabilizing agent. The moiety is filled in the lipid bilayer. The lipid bilayer stabilizing agent is steroid which is incorporated in the lipid bilayer. The lipid bilayer stabilizing agent is selected from the group consisting of sterol or a derivative thereof, spingolipid or a derivative thereof, and a combination thereof. The lipid bilayer stabilizing agent is selected from the group consisting of cholesterol, beta-cholesterol, sistosterol, ergosterol, stigmasterol, 4,22 stigmastadiene-3-one, stigmasterol acetate, lanosterol, and a combination thereof. [Reference numerals] (AA) Calcein release(%); (BB) Cholesterol molar ratio: 25.8; (CC) Cholesterol molar ratio: 41; (DD) Temperature(°C);
Abstract:
PURPOSE: A synchronizing method between devices, a user device, and recording medium are provided to connect devices according to the generation of an event and to synchronize devices. CONSTITUTION: A processor connects a user device to a PC(Personal Computer)(S401). The processor requests the conversion about receiving target data to the PC(S402). The processor releases connection(S403). If a first event is generated, the processor connects the user device to the PC(S404,S405). The processor receives the converted data from the PC(S406).